Azacitidine

Also known as: Azacytidine

Description

Azacitidine is believed to exert its antineoplastic effects by multiple mechanisms including cytotoxicity on abnormal haematopoietic cells in the bone marrow and hypomethylation of DNA. The cytotoxic effects of azacitidine may result from multiple mechanisms, including inhibition of DNA, RNA and protein synthesis, incorporation into RNA and DNA, and activation of DNA damage pathways.

Medicine classification

ATC Code
Title
Class
Azacitidine
L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01B Antimetabolites → L01BC Pyrimidine analogues

Medicines

Drug
Countries

Austria

Australia Hong Kong Singapore

Australia

Austria

Lithuania United States

Australia Austria Canada Cyprus France

Hong Kong Singapore

Product monographs

2D Molecule Structure

2D representation of molecule

Unique Ingredient Identifier (UNII)

M801H13NRU - AZACITIDINE

CAS Registry Number

320-67-2 - azacitidine

SNOMED-CT

412328000 - Azacitidine (substance)